Mostrar el registro sencillo del ítem
dc.contributor.author
Marin, Gustavo Horacio
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.date.available
2020-06-24T22:00:22Z
dc.date.issued
2020-03
dc.identifier.citation
Marin, Gustavo Horacio; Facts and reflections on COVID-19 and anti-hypertensives drugs; Japan Medical Society; Drug Discoveries & Therapeutics; 14; 2; 3-2020; 104-107
dc.identifier.issn
1881-7831
dc.identifier.uri
http://hdl.handle.net/11336/108169
dc.description.abstract
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensivedrug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin IIreceptor blockers (e.g. losartan), many patients from South America, Central America or Spain,have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominousconsequences due to this drop out. For this reason, it is necessary to quickly warn about thissituation and the risks associated with it.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Japan Medical Society
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
COVID-19
dc.subject
Medicines
dc.subject
Side effects
dc.subject
ACE-2
dc.subject.classification
Farmacología y Farmacia
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Medicina Básica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Facts and reflections on COVID-19 and anti-hypertensives drugs
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2020-06-24T21:44:50Z
dc.journal.volume
14
dc.journal.number
2
dc.journal.pagination
104-107
dc.journal.pais
Japón
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
Tokyo
dc.description.fil
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.journal.title
Drug Discoveries & Therapeutics
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.5582/ddt.2020.01017
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01017/_article
Archivos asociados